Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 CAD | -7.14% |
|
-7.14% | -13.33% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Laboratory Testing
51.7
%
| 4 | 50.3 % | 3 | 51.7 % | -9.85% |
Safety and other Compliance
45.5
%
| 4 | 49.7 % | 3 | 45.5 % | -19.69% |
Management Fees
2.8
%
| - | - | 0 | 2.8 % | - |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -12.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Shippen
CEO | Chief Executive Officer | 43 | 01/19/01 |
Sarah Zilik
DFI | Director of Finance/CFO | - | 15/21/15 |
Boris Novansky
PSD | President | - | 15/21/15 |
Chief Tech/Sci/R&D Officer | - | 15/21/15 | |
Micah Simmons
PRN | Corporate Officer/Principal | - | - |
George Furtado
PRN | Corporate Officer/Principal | - | 15/21/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Greg Taylor
CHM | Chairman | - | 15/21/15 |
Peter Shippen
CEO | Chief Executive Officer | 43 | 01/19/01 |
Scott Secord
BRD | Director/Board Member | - | 02/18/02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 162,254,339 | 102,580,558 ( 63.22 %) | 0 | 63.22 % |
Company contact information
Britannia Life Sciences, Inc.
120 Adelaide Street West Suite 2400
M5H 1T1, Toronto
+416-433-9259
http://www.britannia.life![address Britannia Life Sciences Inc.(BLAB)](https://cdn.zonebourse.com/static/address/129600276.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.33% | 7.71M | |
+13.21% | 8.12B | |
+4.64% | 7.45B | |
-17.32% | 4.88B | |
-8.76% | 3.62B | |
-20.43% | 3.17B | |
-11.51% | 1.21B | |
-31.91% | 1.04B | |
-15.60% | 862M | |
-8.57% | 879M |
- Stock Market
- Equities
- BLAB Stock
- Company Britannia Life Sciences Inc.